|
| US4001388 | 2 Jul 1975 | 4 Ene 1977 | Alza Corporation | Ophthalmological bioerodible drug dispensing formulation |
| US4066747 | 8 Abr 1976 | 3 Ene 1978 | Alza Corporation | Polymeric orthoesters housing beneficial drug for controlled release therefrom |
| US4115544 | 10 Nov 1977 | 19 Sep 1978 | Alza Corporation | Ocular system made of bioerodible esters having linear ether |
| US4155992 | 19 Oct 1977 | 22 May 1979 | Alza Corporation | Pharmaceutical composition of poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having carbonyloxy functionality with drug |
| US4180064 | 15 Dic 1976 | 25 Dic 1979 | Alza Corporation | System for delivering agent to environment of use over prolonged time |
| US4249531 | 5 Jul 1979 | 10 Feb 1981 | Alza Corporation | Bioerodible system for delivering drug manufactured from poly(carboxylic acid) |
| US4381772 | 20 Nov 1980 | 3 May 1983 | | Bioerodible diaphragm |
| US4622244 | 23 Ago 1984 | 11 Nov 1986 | The Washington University | Process for preparation of microcapsules |
| US4853224 | 22 Dic 1987 | 1 Ago 1989 | Visionex | Biodegradable ocular implants |
| US4865846 | 3 Jun 1988 | 12 Sep 1989 | | Drug delivery system |
| US4882150 | 1 May 1989 | 21 Nov 1989 | | Drug delivery system |
| US4923699 | 3 Jun 1988 | 8 May 1990 | | Eye treatment suspension |
| US4923700 | 3 Jun 1988 | 8 May 1990 | | Artificial tear suspension |
| US4997652 | 31 May 1989 | 5 Mar 1991 | Visionex | Biodegradable ocular implants |
| US5292517 | 25 Feb 1992 | 8 Mar 1994 | Allergan, Inc. | pH sensitive, reversible gelling, copolymeric erodible drug delivery system |
| US5466233 | 25 Abr 1994 | 14 Nov 1995 | Escalon Ophthalmics, Inc. | Tack for intraocular drug delivery and method for inserting and removing same |
| US5518732 | 14 Feb 1995 | 21 May 1996 | Chiron Vision, Inc. | Bio-erodible ophthalmic shield |
| US5660851 | 5 Jun 1995 | 26 Ago 1997 | Yissum Research Development Company of the Hebrew Univ. of Jerusalem | Ocular inserts |
| US5731005 | 6 Jun 1995 | 24 Mar 1998 | Vitaphore Corporation | Hydrogel-based microsphere drug delivery systems |
| US5833665 | 7 Jun 1995 | 10 Nov 1998 | Integra LifeSciences I, Ltd. | Polyurethane-biopolymer composite |
| US6071447 | 8 Oct 1997 | 6 Jun 2000 | Integra LifeScineces I, Ltd. | Method of making a polyurethane-biopolymer composite |
| US6217896 | 1 Abr 1999 | 17 Abr 2001 | UAB Research Foundation | Conjunctival inserts for topical delivery of medication or lubrication |
| US6551584 | 10 Oct 2001 | 22 Abr 2003 | Pharmacia & Upjohn Company | Topical antibiotic composition for treatment of eye infection |
| US6596293 | 17 May 2000 | 22 Jul 2003 | Integra Lifesciences I, Ltd. | Polyurethane-biopolymer composite |
| US6726918 | 20 Oct 2000 | 27 Abr 2004 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
| US7585517 | 20 Sep 2004 | 8 Sep 2009 | Macusight, Inc. | Transscleral delivery |
| US7625582 | 20 Abr 2007 | 1 Dic 2009 | Allergan, Inc. | Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| US7691829 | 4 Mar 2005 | 6 Abr 2010 | | Composition and method for healing tissues |
| US7767223 | 11 Jul 2005 | 3 Ago 2010 | Allergan, Inc. | Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use |
| US7846468 | 3 Nov 2008 | 7 Dic 2010 | Allergan, Inc. | Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| US8034366 | 31 Oct 2007 | 11 Oct 2011 | Allergan, Inc. | Ocular implant made by a double extrusion process |
| US8034370 | 31 Oct 2007 | 11 Oct 2011 | Allergan, Inc. | Ocular implant made by a double extrusion process |
| US8043628 | 31 Oct 2007 | 25 Oct 2011 | Allergan, Inc. | Methods for reducing edema |
| US8063031 | 23 Dic 2009 | 22 Nov 2011 | Allergan, Inc. | Implants and methods for treating inflammation-mediated conditions of the eye |
| US8071120 | 30 Mar 2006 | 6 Dic 2011 | Allergan, Inc. | Methods for treating neovascularization and intravitreal implants |
| US8088407 | 7 Sep 2007 | 3 Ene 2012 | Allergan, Inc. | Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| US8222271 | 23 Mar 2007 | 17 Jul 2012 | Santen Pharmaceutical Co., Ltd. | Formulations and methods for vascular permeability-related diseases or conditions |
| US8242099 | 12 Oct 2011 | 14 Ago 2012 | Allergan, Inc. | Implants and methods for treating inflammation-mediated conditions of the eye |
